Nama's AI scorecard currently rates Fresenius Medical Care Hold (4.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is FMS's P/E ratio?

Fresenius Medical Care trades at a trailing price-to-earnings ratio of 10.2.

When does FMS report earnings?

Fresenius Medical Care's next scheduled report is on Feb 23, 2027. Analysts expect EPS of $0.37.

What is the FMS price target?

The median analyst price target from 7 analysts is $23.52, with a range of $16.13 – $34.84.

Is FMS Shariah compliant?

Nama's AAOIFI-style screen reads Fresenius Medical Care as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does FMS pay a dividend?

Yes — Fresenius Medical Care's dividend yield is 3.7%.

Nama Insights

Fresenius Medical Care (FMS)

Healthcare · Medical Care Facilities · NYSE

Fresenius Medical Care (FMS) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $12.15B, a trailing price-to-earnings ratio of 10.2 and a free-cash-flow yield of 14.5%. Over the most recent reported fiscal year, revenue grew 1.5% and free cash flow per share grew 5.5%. Nama's AI scorecard rates it Hold, 4.7 out of 10. On 12-month momentum it ranks in the trailing band of its market.

AI scorecard

Hold · 4.7/10

The sections balance. As of Nov 7, 2026.

Momentum

Trailing · -14.8% over 12 months ex. last

Bottom 20% of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-33.9%

How far the last close sits under the highest price of the past five years.

Market cap	$12.15B
Trailing P/E	10.2
Price / book	0.4
Price / sales	0.6
FCF yield	14.5%
Dividend yield	3.7%
Gross margin	26.4%
Operating margin	10.1%
Net margin	4.8%
Revenue growth (YoY)	+1.5%
Revenue growth (3-yr annual)	+0.4%
EPS growth (YoY)	+39.6%
FCF/share growth (YoY)	+5.5%
Beta	0.8
Exchange	NYSE
Sector	Healthcare
Industry	Medical Care Facilities

FMS earnings

Next report: Feb 23, 2027 (Q4 2026, EPS estimate $0.37). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 2, 2026	$0.56	$0.53	+5.7%	$5.51B
Q2 2026	Aug 3, 2026	$0.56	$0.50	+12.0%	$5.42B
Q1 2026	May 3, 2026	$0.46	$0.50	-8.0%	$5.15B
Q4 2025	Feb 24, 2026	$0.72	$0.55	+30.9%	$5.66B

FMS analyst price target

Median target $23.52 from 7 analysts, ranging $16.13 – $34.84.

Medical Care Facilities peers

Ticker	Company	Market cap	P/E
HCA	HCA Healthcare	$103.40B	16.5
THC	Tenet Healthcare	$22.55B	12.7
EHC	Encompass Health	$13.50B	22.4
DVA	DaVita	$12.04B	13.6
UHS	Universal Health Services	$11.52B	8.6
ENSG	Ensign Group	$10.56B	23.8
PACS	PACS Group	$7.87B	20.1
CHE	Chemed	$6.84B	21.2

Explore live FMS data on Nama Insights →

FMS FAQ

Is FMS a buy?: Nama's AI scorecard currently rates Fresenius Medical Care Hold (4.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is FMS's P/E ratio?: Fresenius Medical Care trades at a trailing price-to-earnings ratio of 10.2.
When does FMS report earnings?: Fresenius Medical Care's next scheduled report is on Feb 23, 2027. Analysts expect EPS of $0.37.
What is the FMS price target?: The median analyst price target from 7 analysts is $23.52, with a range of $16.13 – $34.84.
Is FMS Shariah compliant?: Nama's AAOIFI-style screen reads Fresenius Medical Care as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does FMS pay a dividend?: Yes — Fresenius Medical Care's dividend yield is 3.7%.